PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-243

  1. 555 Posts.
    lightbulb Created with Sketch. 229
    Pool, you are absolutely right in point 1, but without a deal / a distribution partnership with big pharma there is no "release" of iPPS to the market.. They need a deal for it to get to the masses.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.